Print Send My Information

Purpose

This investigator-initiated, multicenter, international, retrospective registry aims to investigate outcomes of patients with atrial functional mitral regurgitation, as treated in clinical routine.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • functional mitral regurgitation - left ventricular ejection fraction ≥50%

Exclusion Criteria

  • age under 18 years - known regional wall movement disorders

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Arm Groups

ArmDescriptionAssigned Intervention
Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER) Patients who underwent mitral valve transcatheter edge-to-edge repair. All devices may be included.
Guideline Directed Medical Therapy Patients who underwent conservative management with guideline directed medical therapy.
Transcatheter Mitral Valve Replacement (TMVR) Patients who underwent transcatheter mitral valve replacement. All devices may be included.

Recruiting Locations

Montefiore Medical Center
The Bronx, New York
Contact:
Azeem Latib, MD
(718) 920-4212
mlatib@montefiore.org

More Details

NCT ID
NCT06911099
Status
Recruiting
Sponsor
University Hospital of Cologne

Study Contact

Philipp von Stein, MD
646-321-8145
philipp.von-stein@uk-koeln.de

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.

For help using this page: trialstoday@researchmatch.org or call 855-514-7001

ResearchMatch is funded in part by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, led by the NIH’s National Center for Advancing Translational Sciences (NCATS), grants UL1TR000445 and 1U54RR032646-01, and grant U24TR001579 from NCATS and the National Library of Medicine. The content of this website is solely the responsibility of ResearchMatch and Vanderbilt University and does not necessarily represent the official views of the NIH, NCATS, or NLM.

Vanderbilt University Medical Center